A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA and narrowband red light in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S48, 2019. DOI: 10.25251/skin.3.supp.48. Disponível em: https://skin.dermsquared.com/skin/article/view/776. Acesso em: 2 may. 2026.